Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

There’s a strong valuation case for doing so. Haleon to invest $54 mln in US R&D centre to boost product innovation Consumer healthcare company Haleon said on Wednesday it will invest $54 ...

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Haleon PLC closed 11.52% short of its 52-week high of £4.18, which the company reached on March 4th.